Showing 1 - 9 results of 9 for search 'C. David Pauza', query time: 0.03s Refine Results
  1. 1
    Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.

    Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells. by Haishan Li, C David Pauza

    Published 2009-11-01
    Get full text
    Article
  2. 2
    Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.

    Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy. by Bhawna Poonia, C David Pauza

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models

    Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models by Mei-Ling Liou, Tyler Lahusen, Haishan Li, Haishan Li, Lingzhi Xiao, C. David Pauza, C. David Pauza

    Published 2022-10-01
    Get full text
    Article
  4. 4
    High affinity allele for the gene of FCGR3A is risk factor for HIV infection and progression.

    High affinity allele for the gene of FCGR3A is risk factor for HIV infection and progression. by Bhawna Poonia, Gustavo H Kijak, C David Pauza

    Published 2010-12-01
    Get full text
    Article
  5. 5
    Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure

    Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure by Haishan Li, Tyler Lahusen, Lingzhi Xiao, Nidal Muvarak, Jana Blazkova, Tae-Wook Chun, C. David Pauza

    Published 2020-06-01
    Get full text
    Article
  6. 6
    Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial

    Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial by Nidal Muvarak, Haishan Li, Tyler Lahusen, Jeffrey A. Galvin, Princy N. Kumar, C. David Pauza, José Bordon

    Published 2022-11-01
    Get full text
    Article
  7. 7
    Circulating natural killer and γδ T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus

    Circulating natural killer and γδ T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus by Juan D Rodas, Cristiana Cairo, Mahmoud Djavani, Juan Carlos Zapata, Tracy Ruckwardt, Joseph Bryant, C David Pauza, Igor S Lukashevich, Maria S Salvato

    Published 2009-07-01
    Get full text
    Article
  8. 8
    Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor

    Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor by Xiaoyang Liu, Senthilkumar Palaniyandi, Iowis Zhu, Jin Tang, Weizhong Li, Xiaoling Wu, Susan Park Ochsner, C. David Pauza, Jeffrey I. Cohen, Xiaoping Zhu

    Published 2019-07-01
    Get full text
    Article
  9. 9
    Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population

    Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population by Shashwatee Bagchi, Shana AB Burrowes, Lori E Fantry, Mian B Hossain, Gemechis H Tollera, Shyamasundaran Kottilil, C David Pauza, Michael Miller, Mona Baumgarten, Robert R Redfield

    Published 2017-08-01
    Get full text
    Article

Search Tools: